Interferon Alpha Receptor 2 and Kidney Cancer
Author Information
Author(s): Kamai Takao, Yanai Yoshiaki, Arai Kyoko, Abe Hideyuki, Yamanishi Tomonori, Kurimoto Masashi, Yoshida Ken-Ichiro
Primary Institution: Dokkyo Medical University
Hypothesis
The study investigates the role of interferon alpha receptor 2 (IFNAR2) in renal cell carcinoma (RCC) and its association with metastasis.
Conclusion
Higher levels of IFNAR2 are linked to the progression and metastasis of renal cell carcinoma.
Supporting Evidence
- A high T/N ratio of IFNAR2 correlated with poor differentiation and metastasis.
- Patients with a higher IFNAR2 T/N ratio had a shorter overall survival.
- The study found that IFNAR2 levels were higher in tumors with metastases compared to those without.
Takeaway
This study found that a specific protein related to the immune system, called IFNAR2, can help doctors understand how aggressive kidney cancer is.
Methodology
The study measured IFNAR mRNA levels in tumor and non-tumor samples from 103 patients using RT-PCR and Western blotting.
Limitations
The follow-up period was too short to draw definitive conclusions.
Participant Demographics
103 Japanese patients (71 men, 32 women), aged 33 to 81 years (mean age 63.7 years).
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website